Self-collection kits for cervical cancer screening have begun to ship to healthcare facilities, according to a Sept. 5 report from ABC News.
The kits offer patients and physicians an alternative to Pap smears, allowing a patient to administer the swab privately in a healthcare setting.
The FDA approved the kits in May and researchers from the medical device manufacturing company BD are working toward getting an at-home version of the test approved, according to ABC News.